Lundbeck
HLUN-B.CO
#2771
Rank
โ‚น538.60 B
Marketcap
โ‚น542.86
Share price
0.92%
Change (1 day)
11.35%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2025 (TTM): โ‚น66.53 Billion

According to Lundbeck's latest financial reports the company's current earnings are โ‚น3.80 Billion. , an increase over its 2024 earnings that were of โ‚น51.85 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น71.81 B38.47%
2024 โ‚น51.85 B25.74%
2023 โ‚น41.24 B21.77%
2022 โ‚น33.87 B31.57%
2021 โ‚น25.74 B-4.61%
2020 โ‚น26.98 B-45.06%
2019 โ‚น49.12 B-34.04%
2018 โ‚น74.48 B12.83%
2017 โ‚น66.01 B93.99%
2016 โ‚น34.02 B-137.28%
2015 -โ‚น91.28 Billion-1246.24%
2014 โ‚น7.96 B-72.36%
2013 โ‚น28.80 B4.38%
2012 โ‚น27.59 B-55.18%
2011 โ‚น61.58 B5.65%
2010 โ‚น58.28 B-5.9%
2009 โ‚น61.94 B